Exploiting Metabolic Adaptations to Overcome Dabrafenib Treatment Resistance in Melanoma Cells

The authors dissected signaling and mitochondrial alterations that characterize the transition from BRAF-specific inhibitors responsiveness to resistance in A375 melanoma cells.